Vaccination against COVID-19 among healthcare workers as a cocoon strategy for people living with HIV

IF 3.5 4区 医学 Q2 IMMUNOLOGY
Agata Skrzat-Klapaczyńska , Justyna Kowalska , Filip Fijołek , Marcin Paciorek , Carlo Bieńkowski , Dominika Krogulec , Andrzej Horban
{"title":"Vaccination against COVID-19 among healthcare workers as a cocoon strategy for people living with HIV","authors":"Agata Skrzat-Klapaczyńska ,&nbsp;Justyna Kowalska ,&nbsp;Filip Fijołek ,&nbsp;Marcin Paciorek ,&nbsp;Carlo Bieńkowski ,&nbsp;Dominika Krogulec ,&nbsp;Andrzej Horban","doi":"10.1016/j.jve.2024.100377","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Healthcare professionals working in infectious disease units are often engaged in the care of patients with HIV infection. A cocoon vaccination strategy may protect those who are immunocompromised from a severe course of COVID-19.</p></div><div><h3>Methods</h3><p>The research was conducted between January 2021 and June 2022. The study participants were 450 healthcare workers (HCWs) from the Hospital for Infectious Diseases in Warsaw who were vaccinated against COVID-19 with the BNT162b2 mRNA vaccine (Pfizer-BioNTech) –, thefirst available type of vaccine in Poland. Sera were collected according to the schedule of the study. Statistical analyses were performed with non-parametric tests: Wilcoxon's test was used to compare dependent numerical variables, and Fisher's exact test and the Chi-squared test to compare categorical variables. A <em>p</em> value of &lt;0.05 was considered statistically significant.</p></div><div><h3>Results</h3><p>Among the 450 HCWs working in the Hospital for Infectious Diseases in Warsaw 412 (91,5 %) were vaccinated against COVID-19. In total 170 (41,3 %) vaccinated HCWs were included in the final analysis. Their median age was 51 years [interquartile range (IQR): 41–60 years] and median body mass index (BMI) was 25.10 [IQR: 22.68–29.03]. Most of the cohort consisted of women (n = 137, 80.59 %), with the majority working directly with patients (n = 137, 73.21 %). It was found that as early as 14 days after the second dose of the vaccine, 100 % of the study participants achieved a positive result for SARS CoV-2 S-RBD antibodies. There were 168 subjects who had had a COVID-19 diagnosis before entering study and after vaccination 65 HCWs was diagnosed with COVID-19.</p></div><div><h3>Conclusions</h3><p>Due to the fact that people living with HIV with severe immunodeficiency may have an incomplete immune response to COVID vaccination and be at risk of a severe course of the disease, the cocoon strategy of vaccinating medical personnel may be beneficial for these patients.</p></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 2","pages":"Article 100377"},"PeriodicalIF":3.5000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2055664024000141/pdfft?md5=8d5f3d22dd455405e92483c07be9374d&pid=1-s2.0-S2055664024000141-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virus Eradication","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2055664024000141","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Healthcare professionals working in infectious disease units are often engaged in the care of patients with HIV infection. A cocoon vaccination strategy may protect those who are immunocompromised from a severe course of COVID-19.

Methods

The research was conducted between January 2021 and June 2022. The study participants were 450 healthcare workers (HCWs) from the Hospital for Infectious Diseases in Warsaw who were vaccinated against COVID-19 with the BNT162b2 mRNA vaccine (Pfizer-BioNTech) –, thefirst available type of vaccine in Poland. Sera were collected according to the schedule of the study. Statistical analyses were performed with non-parametric tests: Wilcoxon's test was used to compare dependent numerical variables, and Fisher's exact test and the Chi-squared test to compare categorical variables. A p value of <0.05 was considered statistically significant.

Results

Among the 450 HCWs working in the Hospital for Infectious Diseases in Warsaw 412 (91,5 %) were vaccinated against COVID-19. In total 170 (41,3 %) vaccinated HCWs were included in the final analysis. Their median age was 51 years [interquartile range (IQR): 41–60 years] and median body mass index (BMI) was 25.10 [IQR: 22.68–29.03]. Most of the cohort consisted of women (n = 137, 80.59 %), with the majority working directly with patients (n = 137, 73.21 %). It was found that as early as 14 days after the second dose of the vaccine, 100 % of the study participants achieved a positive result for SARS CoV-2 S-RBD antibodies. There were 168 subjects who had had a COVID-19 diagnosis before entering study and after vaccination 65 HCWs was diagnosed with COVID-19.

Conclusions

Due to the fact that people living with HIV with severe immunodeficiency may have an incomplete immune response to COVID vaccination and be at risk of a severe course of the disease, the cocoon strategy of vaccinating medical personnel may be beneficial for these patients.

在医护人员中接种 COVID-19 疫苗作为艾滋病毒感染者的破茧策略
导言在传染病科工作的医护人员经常要护理艾滋病感染者。蚕茧疫苗接种策略可保护免疫力低下者免受 COVID-19 的严重感染。研究参与者是华沙传染病医院的 450 名医护人员,他们接种了 BNT162b2 mRNA 疫苗(辉瑞生物技术公司)--波兰第一种可用的 COVID-19 疫苗。血清按照研究计划采集。统计分析采用非参数检验:Wilcoxon检验用于比较因果数字变量,Fisher精确检验和Chi-squared检验用于比较分类变量。结果在华沙传染病医院工作的 450 名医护人员中,有 412 人(91.5%)接种了 COVID-19 疫苗。共有 170 名(41.3%)已接种疫苗的医务人员被纳入最终分析。他们的年龄中位数为 51 岁 [四分位数间距 (IQR):41-60 岁],体重指数 (BMI) 中位数为 25.10 [四分位数间距 (IQR):22.68-29.03]。队列中大多数为女性(n = 137,80.59%),其中大多数直接与病人打交道(n = 137,73.21%)。研究发现,早在接种第二剂疫苗 14 天后,100% 的研究参与者都获得了 SARS CoV-2 S-RBD 抗体阳性结果。结论由于严重免疫缺陷的艾滋病病毒感染者对 COVID 疫苗接种的免疫反应可能不完全,有可能出现严重的病程,因此为医务人员接种疫苗的蚕茧策略可能对这些患者有益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Virus Eradication
Journal of Virus Eradication Medicine-Public Health, Environmental and Occupational Health
CiteScore
6.10
自引率
1.80%
发文量
28
审稿时长
39 weeks
期刊介绍: The Journal of Virus Eradication aims to provide a specialist, open-access forum to publish work in the rapidly developing field of virus eradication. The Journal covers all human viruses, in the context of new therapeutic strategies, as well as societal eradication of viral infections with preventive interventions. The Journal is aimed at the international community involved in the prevention and management of viral infections. It provides an academic forum for the publication of original research into viral reservoirs, viral persistence and virus eradication and ultimately development of cures. The Journal not only publishes original research, but provides an opportunity for opinions, reviews, case studies and comments on the published literature. It focusses on evidence-based medicine as the major thrust in the successful management of viral infections.The Journal encompasses virological, immunological, epidemiological, modelling, pharmacological, pre-clinical and in vitro, as well as clinical, data including but not limited to drugs, immunotherapy and gene therapy. It is an important source of information on the development of vaccine programs and preventative measures aimed at virus eradication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信